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ABSTRACT 
Rasapravicharana cikitsa is the administration of drugs in accordance with the Rasam (taste) after 
assessing the Doshic imbalance in diseases. The basic approach of Ayurveda is to normalize the 
Doshas in aggravated or depleted conditions occurred in the manifestation of disease. The objective 
of the study was to assess the effect of Rasapravicharana cikitsa (taste specific drug therapy) in 
aggravated Kapha dosha of Kapha dominant Tamaka swasa (asthma). The study was conducted on 
10 patients between the age group 16 to 70 yrs of both the sexes. The patients were administered 
with Katu (pungent) rasa drug ie, powder of the dried fruit of Maricham (Piper nigrum Linn) at the 
dose of 500 mg, Tikta (bitter) rasa drug i.e., dried Vasa leaf powder (Adhatoda vasica Nees) at the 
dose of 3gm, and Kashaya (astringent) rasa drug i.e., powder of the dried fruit pericarp of Haritaki 
(Terminalia chebula (Gaertn.) Retz.) at the dose of 3gm, 8 AM and 8 PM after food daily in luke 
warm water respectively for a period of two weeks each. 
The Katu rasa drug administered for 14 days produced highly significant reduction in dyspnoea, 
cough bout frequency, wheeze, expectoration of sputum and quantity of sputum, and significant 
improvement in PEFRate. But no significant improvement was observed in PEF%. The 
administration of Tikta rasa drug in the next 14 days resulted in highly significant reduction in 
cough bout frequency and expectoration of sputum and significant reduction in dyspnoea. The 
reduction was maintained in other signs and symptoms. The Kashaya rasa drug used in the last 14 
days significantly improved PEFRate. Reduction in other signs and symptoms was maintained. The 
management according to Rasapravicharana cikitsa has a significant role in the pacification of 
Doshas involved in the manifestation of diseases. 
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INTRODUCTION 
The fundamental approach in the treatment 
of diseases in Ayurveda is the management of 
aggravated or depleted Doshas by utilizing the tastes 
(rasas) of drugs. This is evident from the descriptions 
in the classical treatises like Charaka Samhita, 
Susruta Samhita, Ashtanga samgraham, Ashtanga 
hridayam and many more. It is the classical Ayurvedic 
treatise in 6th century BC Kasyapa Saṃhita that 
highlights the scientific approach with a term 
‘Rasapravicharana cikitsa’ to popularize the 
principles in the practice of this system of medicine.[1] 
The term ‘Rasapravicharana cikitsa’ is 
composed of three words - rasa, Pravicharana and 
cikitsa. Here ‘rasa’ denotes the taste of the substance 
or drug (Dravya). The word ‘Parvicharana’ stands for 
the specific or distinctive usage and ‘cikitsa’ for 
treatment. So ‘Rasapravicharana cikitsa’ is the 
treatment of disease with the specific usage based on 
the taste of drugs.  
Taste is the sense of the gustatory organ, 
tongue. Rasas are six in number and they are Sweet 
(madhuram), Sour (amla), Salt (lavana), Acrid (katu), 
Bitter (tikta) and Astringent (kashaya). It is according 
to the taste that individuals select foodstuffs and this 
link of taste with the substance (dravya) and body 
(sareera) is responsible for the biological regulation 
of different systems. Hence the bioregulatory 
principles of the body i.e., Doshas - Vata, Pitta and 
Kapha - are primarily controlled by the taste of the 
Dravya used as food or medicine. 
Taste or Rasas of substance are solely 
responsible for the pacification (samana) and 
aggravation (kopana) of Doshas in the body. Acharyas 
Charaka, Susrutha, Vagbhata and Bhavamisra 
described that the drugs having sweet (madhura), 
sour (amla) and saline (lavana) Rasas alleviate Vata 
dosha. The Rasas astringent (kashaya), sweet (svadu) 
and bitter (tikta) pacifies Pitta dosha and astringent 
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(kashaya), pungent (katu) and bitter (tikta) mitigate 
Sleshma dosha. The other Rasas cause aggravation of 
Vata, Pitta and Kapha doshas accordingly.[2-5] 
Tamaka swasa is one among the five 
Swasarogas or respiratory diseases classified by 
ancient scholars of Ayurveda.[6-9] Apart from the 
other four Swasarogas - Kshudra, Chinna, Maha and 
Urdha, Tamaka swasa is caused predominantly due to 
the abundance of Kapha dosha.[10-12] Dyspnoea 
(Ativega pratamyata), cough (Kasam), wheeze 
(khurkhurakam), expectoration of sputum (Sakapha 
khoshana) are the important signs and symptoms of 
Tamaka swasa.[13-20] The Lakshanas of Tamaka swasa 
explained in Ayurvedic classics very well suites with 
the classical signs and symptoms of asthma described 
in the text books of Modern medicine. So it can be 
understand that Tamaka swasa is a type of 
respiratory disease in which the physiological 
function of respiration and exchange of air is 
seriously affected.[21] 
Acharya Kasyapa elaborately discussed about 
the sequence of administration of Rasas in 
pathological condition according to the Doshas. In the 
diseases of Kapha dominance the physician should 
use the pungent (Katu), bitter (Tikta) and astringent 
(Kashaya) rasas in proper combination and in 
sequential order for the treatment. The initially used 
pungent taste destroys rapidly the sliminess 
(paichilyam) and heaviness (Gouravam) of 
aggravated Kapha dosha. Later on the bitter taste 
reduces (Hrasayati) the sweetness of mouth (Asya 
Madhuryam) and desiccates (Samsoshayati) the 
Kapha. The astringent taste diminishes 
(Samgrahana) and extracts unctuousness (Sneha 
avakarsanam) property of Kapha dosha.[22] Hence a 
case series study was conducted to assess the effect 
of Rasapravicharana cikitsa (taste specific drug 
therapy) in aggravated Kapha dosha of Kapha 
dominant Tamaka swasa (asthma). 
MATERIALS AND METHODS 
 10 patients suffering from Kapha dominant 
Tamaka swasa (asthma) between the age group 16 to 
70 yrs of both the sexes were selected from the OPD 
of the Department of Dravyaguna, Govt. Ayurveda 
College, Thiruvananthapuram during the period April 
2016 to August 2016. Selected patients were given 
Katu (Acrid or Pungent) rasa drug (by means of 
powder of the dried fruit of Maricham (Piper nigrum 
Linn) at the dose of 500 mg), Tikta (Bitter) rasa drug 
(by means of dried Vasa leaf powder (Adhatoda 
vasica Nees) at the dose of 3 gm) and Kashaya 
(Astringent) rasa drug (by means of powder of the 
dried fruit pericarp of Haritaki (Terminalia chebula 
(Gaertn.) Retz.) at the dose of 3 gm) 8 AM and 8 PM 
twice daily in luke warm water respectively for a 
period of two weeks each. 
The assessments were done by subjective and 
objective criteria. The subjective criteria analyzed 
were dyspnoea, cough bout frequency, wheeze, 
expectoration of sputum and functional assessment 
PEF % personal best. Objective criteria were quantity 
of sputum and Peak Expiratory Flow Rate (PEFRate). 
The symptoms and signs were noted on 0th day or 
before treatment, after 14th day of treatment, after 
28th day of treatment and after 42nd day or after 
treatment. 
The symptom dyspnoea was observed and 
evaluated according to the grade recommended by 
Medical Research Council Dyspnoea scale of United 
Kingdom.[23] 
Grade 0:  No breathlessness (Absent) 
Grade 1: Not troubled by breathlessness except 
on strenuous exercise (Mild) 
Grade 2: Shortness of breath when hurrying on 
the level or walking up a slight hill  
(Moderate) 
Grade 3: Walks slower than most people on the 
level, stops after a mile or so, or stops 
after 15 minutes walking at own pace 
(Severe) 
Grade 4: Stops for breath after walking about 100 
yards or after a few minutes on level 
ground (Very Severe) 
Grade 5: Too breathless to leave the house or 
breathless when dressing or undressing 
(Very Severe) 
The frequency of cough bouts were assessed 
by grades and were classified as mild, moderate, 
severe and very severe. 
Grade 0:  No cough (Absent) 
Grade 1: Occasional hems (Mild) 
Grade 2: Less than 3 cough bouts (Moderate)  
Grade 3: 3 – 7 cough bouts (Severe) 
Grade 4: More than 8 cough bouts (Very Severe) 
The assessment of the symptom 
wheeze was done according to the grades of 
National Heart, Lung, Blood Institute, National 
Institute of Health, US Department of Health 
and Human services.[24] 
Grade 0: No wheeze (Absent) 
Grade 1: Often only end expiratory (Mild) 
Grade 2: Loud; throughout exhalation (Moderate) 
Grade 3: Usually loud and widespread; throughout 
exhalation (Severe) 
Grade 4: Usually loud and widespread; throughout 
inhalation and exhalation (Very Severe) 
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Based on the nature, expectoration of sputum 
was graded as mild, moderate, severe and very 
severe. 
Grade 0: No expectoration of sputum (Absent) 
Grade 1: Little mucoid expectoration (Mild) 
Grade 2: Tenacious mucoid expectoration with traces 
of phlegm (Moderate) 
Grade 3: Tenacious mucoid expectoration with 
moderately thick phlegm (Severe) 
Grade 4: Viscous mucoid expectoration with large 
quantity of thick phlegm (Very Severe) 
The symptom Peak Expiratory Flow % 
personal best was done according to the grades of 
National Heart, Lung, Blood Institute, National 
Institute of Health, US Department of Health and 
Human services.[24] 
Grade 1: > 70% (>550) (Mild) 
Grade 2: 40-69 % (80-550) (Moderate) 
Grade 3: < 40% (50-80) (Severe) 
Grade 4: < 25% (<50) (Very Severe) 
The quantity of sputum expectorated in the 
morning was measured using a tea spoon (containing 
2.5 ml) and assessed in milli litre (ml). Peak 
Expiratory Flow Rate (PEFRate) was measured using 
the equipment ‘Peak Flow Meter’ in the morning and 
was expressed in L/Min. 
RESULTS AND DISCUSSION 
The results of various parameters were 
collected and calculated the mean difference and 
studentized range. The statistical significance of 
mean difference at two weeks interval and before 
and treatment were compared using repeated 
measures ANOVA. 
Table No. 1. Comparison of the effect in Dyspnoea at 2 weeks intervals and before and after treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 1.3 5.448 Yes ** 0.3902 to 2.210 
T14 Vs T28 1 4.191 Yes * 0.0902 to 1.910 
T28 Vs T42 0.4 1.676 No ns -0.5098 to 1.310 
T0 Vs T42 2.7 11.31 Yes *** 1.790 to 3.610 
Table No. 2. Comparison of the effect in Cough bout frequency at 2 weeks intervals and before and after 
treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 1.2 5.555 Yes ** 0.3764 to 2.024 
T14 Vs T28 1.2 5.555 Yes ** 0.3764 to 2.024 
T28 Vs T42 0.6 2.777 No ns -0.2236 to 1.424 
T0 Vs T42 3 13.89 Yes *** 2.176 to 3.824 
Table No. 3. Comparison of the effect in Wheeze at 2 weeks intervals and before and after treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 1.2 4.968 Yes ** 0.2792 to 2.121 
T14 Vs T28 0.7 2.898 No ns -0.2208 to 1.621 
T28 Vs T42 0.6 2.484 No ns -0.3208 to 1.521 
T0 Vs T42 2.5 10.35 Yes *** 1.579 to 3.421 
Table No. 4. Comparison of the effect in Expectoration of sputum at 2 weeks intervals and before and 
after treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 1.2 6.466 Yes *** 0.4924 to 1.908 
T14 Vs T28 1.2 6.466 Yes *** 0.4924 to 1.908 
T28 Vs T42 0.4 2.155 No ns -0.3076 to 1.108 
T0 Vs T42 2.8 15.09 Yes *** 2.092 to 3.508 
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Table No. 5. Comparison of the effect in Peak Expiratory Flow % personal best at 2 weeks intervals and 
before and after treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 0.1 2 No ns -0.09063 to 0.2906 
T14 Vs T28 0 0 No ns -0.1906 to 0.1906 
T28 Vs T42 0 0 No ns -0.1906 to 0.1906 
T0 Vs T42 0.1 2 No ns -0.09063 to 0.2906 
Table No. 6. Comparison of the effect in Quantity of sputum at 2 weeks intervals and before and after 
treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 7.5 8.148 Yes *** 3.991 to 11.01 
T14 Vs T28 3.5 3.803 No ns -0.009295 to 7.009 
T28 Vs T42 1.5 1.63 No ns -2.009 to 5.009 
T0 Vs T42 12.5 13.58 Yes *** 8.991 to 16.01 
Table No. 7. Comparison of the effect in Peak Expiratory Flow Rate (PEFRate) at 2 weeks intervals and 
before and after treatment 
Period of 
Treatment 
Mean 
Difference 
q Significance Summary 95% CI of diff 
T0 Vs T14 -71 3.911 Yes * -140.2 to -1.793 
T14 Vs T28 -68 3.746 No ns -137.2 to 1.207 
T28 Vs T42 -85 4.683 Yes * -154.2 to -15.79 
T0 Vs T42 -224 12.36 Yes *** -293.2 to -154.8 
The Katu rasa drug, Maricham (Piper nigrum 
Linn) administered for 14 days produced highly 
significant reduction in dyspnoea, cough bout 
frequency, wheeze, expectoration of sputum and 
quantity of sputum, and significant improvement in 
PEFRate. But no significant improvement was 
observed in PEF%. The administration of Tikta rasa 
drug Vasa (Adhatoda vasica Nees) in the next 14 days 
resulted in highly significant reduction in cough bout 
frequency and expectoration of sputum and 
significant reduction in dyspnoea. The reduction was 
maintained in wheeze and quantity of sputum, and 
improvement was continued in PEFRate. The kashaya 
rasa drug Haritaki (Terminalia chebula (Gaertn.) 
Retz.) used in the last 14 days significantly improved 
PEFRate. Reduction in dyspnoea, cough bout 
frequency, wheeze, expectoration of sputum and 
quantity of sputum was maintained.  
After 42 days of treatment, ie completion of 
treatment, a highly significant reduction was 
observed in dyspnoea, cough bout frequency, 
wheeze, expectoration of sputum and quantity of 
sputum, and improvement in PEFRate when 
compared to before treatment. No improvement was 
found in PEF% personal best. 
The Katu rasa; Laghu, Tikshna and Ruksha 
Gunas; Ushna veerya; Katu vipaka; Kaphahara and 
Vatasamana actions, and the beneficial effects in the 
diseases Swasam and Kasam helped the drug 
Maricham to reduce the signs of Kapha aggravation 
and pacify the signs and symptoms of Tamaka swasa. 
The pharmacological properties and actions such as 
Tikta rasa, Laghu guna, Seeta veerya, Katu vipaka, 
Kaphasamana and Pittasamana actions, and the 
therapeutic effects in Svasa and Kasa diseases 
favored the drug Vasa to pacify the remaining signs of 
Kapha aggravation and signs and symptoms in 
Tamaka swasa. The drug Haritaki with its Kashaya 
rasa; Laghu, Ruksha and Sara gunas; Ushna veerya; 
Madhura vipaka; Tridoshakhna karma and the actions 
in the diseases Kasam, Kaphaprasekam and Tamaka 
svasam maintained the reduction of aggravated 
Kapha and pacified the signs and symptoms of 
Tamaka swasa. Due to the Rasayana action it 
improved the function of the organ, lung by 
increasing the PEFRate. 
CONCLUSION 
Disease or Roga is caused by the 
derangement of the bio regulatory principles of the 
body, i.e., Doshas. Apart from the disease pacifying 
action (Roga samanatva karma) it is the Rasam or 
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taste of the substance which is used as medicine that 
bring back the Doshas to normalcy in disease. Hence 
the administration of drugs according to rasa has a 
major role in the pacification of Doshas involved in 
the pathology of all diseases. 
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